The Hematologist: The Sickle Cell Clinical Trials Network: One Year In
The ASH Research Collaborative Leadership provides a progress report on the development of the Sickle Cell Disease Clinical Trials Network.
ASH Research Collaborative News
HemOncToday: ASH launches sickle cell disease clinical trials network to accelerate therapy development
The Sickle Cell Disease Clinical Trials Network’s ambitious goal of accelerating development of novel therapies for patients with sickle cell disease was covered by HemOnc Today.
ACN: ASH to Launch SCD Clinical Trials Network
ASH Clinical News featured an announcement that ASH would be creating a sickle cell disease (SCD) clinical trials network to accelerate the development of new therapies.
The Hematologist: Putting In the (Net)Work to Cure SCD
Dr. Charles Chesson provided an update on the ASH Research Collaborative Data Hub in a recent issue of the Hematologist.
ASH RESEARCH COLLABORATIVE
The ASH Research Collaborative (ASH RC) is a non-profit organization established by the American Society of Hematology (ASH) in 2017 to improve the lives of people affected by blood diseases by fostering collaborative partnerships to accelerate progress in hematology. Learn more about ASH RC